Deutsch English Français

Contact

EP0965591

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0965591

EP0965591 - Process for the preparation of (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine [Right-click to bookmark this link]
Former [1999/51]	(s)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine, its salts, synthesis and use in the long term therapy of diabetes mellitus
	[2002/03]
Status	No opposition filed within time limit Status updated on 11.07.2003 Database last updated on 19.10.2024
Most recent event Tooltip	26.06.2009	Change - representative	published on 29.07.2009 [2009/31]
Applicant(s)	For all designated states Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173 55218 Ingelheim am Rhein / DE
	[N/P]
Former [2003/24]	For all designated states Boehringer Ingelheim Pharma GmbH & Co.KG Binger Strasse 173 55218 Ingelheim am Rhein / DE
Former [2000/40]	For all designated states Boehringer Ingelheim Pharma KG Binger Strasse 173 55218 Ingelheim am Rhein / DE
Former [1999/51]	For all designated states Boehringer Ingelheim Pharma KG 55216 Ingelheim am Rhein / DE
Inventor(s)	01 / Grell, Wolfgang Dr. Dipl.-Chem. Geschwister-Scholl-Strasse 18 88400 Biberach / DE
	02 / Greischel, Andreas Dr. Hugo-Häring-Strasse 78/1 88400 Biberach / DE
	03 / Zahn, Gabriele, Frau Dr. Spieglerstrasse 4 88499 Riedlingen / DE
	04 / Mark, Michael Dr. Hugo-Häring-Strasse 50 88400 Biberach / DE
	05 / Knorr, Marianne Waldstrasse 39 55218 Ingelheim/Rhein / DE
	06 / Eckhard, Rupprecht In den Weinbergen 9 2353 Guntramsdorf / AT
	07 / Müller, Ulrich Dr. Eichenerstrasse 7/1 88441 Biberach-Stafflangen / DE
	[1999/51]
Representative(s)	Laudien, Dieter, et al Boehringer Ingelheim GmbH ZA Patente Postfach 200 55216 Ingelheim am Rhein / DE
	[2009/31]
Former [2003/33]	Laudien, Dieter, Dr., et al Boehringer Ingelheim GmbH Abteilung Patente, Postfach 200 55216 Ingelheim / DE
Former [2003/25]	Vercaemer, Laurence, et al Cabinet Plasseraud, 84 rue d'Amsterdam 75440 Paris Cedex 09 / FR
Former [1999/51]	Laudien, Dieter, Dr. Boehringer Ingelheim GmbH Abteilung Patente 55216 Ingelheim / DE
Application number, filing date	99101810.2	21.06.1991
	[1999/51]
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	EP0965591
	Date:	22.12.1999
	Language:	DE
	[1999/51]
	Type:	B1 Patent specification
	No.:	EP0965591
	Date:	04.09.2002
	Language:	DE
	[2002/36]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	25.10.1999
Classification	IPC:	C07D295/12, A61K31/445	[1999/51]
	CPC:	C07D295/135 (EP); A61K31/451 (EP)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1999/51]
Title	German:	Verfahren zur Herstellung von (S)-3-Methyl-1-(2-piperidino-phenyl)-1-butylamin	[2002/03]
	English:	Process for the preparation of (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine	[2002/03]
	French:	Procédé pour la préparation de (S)-3-methyl-1-(2-piperidino-phényl-1-butylamine	[2002/03]
	Former [1999/51]	(S)-3-Methyl-1-(2-piperidino-phenyl)-1-butylamin, dessen Salze, Herstellung und Verwendung bei der Langzeittherapie des Diabetes mellitus
	Former [1999/51]	(s)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine, its salts, synthesis and use in the long term therapy of diabetes mellitus
	Former [1999/51]	(s)-3-methyl-1-(2-piperidino-phényl-1-butylamine, ses sels, synthèse et utilisation dans la thérapie de longue durée de la diabète mellitus
Examination procedure	23.06.2000	Examination requested [2000/34]
	07.06.2001	Despatch of a communication from the examining division (Time limit: M04)
	29.09.2001	Reply to a communication from the examining division
	17.10.2001	Despatch of a communication from the examining division (Time limit: M04)
	16.11.2001	Reply to a communication from the examining division
	22.01.2002	Despatch of communication of intention to grant (Approval: Yes)
	04.03.2002	Communication of intention to grant the patent
	16.05.2002	Fee for grant paid
	16.05.2002	Fee for publishing/printing paid
Parent application(s) Tooltip	EP91911959.4 / EP0589874
Opposition(s)	05.06.2003	No opposition filed within time limit [2003/35]
Fees paid	Renewal fee
	28.05.1999	Renewal fee patent year 03
	28.05.1999	Renewal fee patent year 04
	28.05.1999	Renewal fee patent year 05
	28.05.1999	Renewal fee patent year 06
	28.05.1999	Renewal fee patent year 07
	28.05.1999	Renewal fee patent year 08
	30.06.1999	Renewal fee patent year 09
	30.06.2000	Renewal fee patent year 10
	02.07.2001	Renewal fee patent year 11
	01.07.2002	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]JPH01131143 ;
		[A]EP0128482 (THOMAE GMBH DR K [DE]) [A] 1-9 * the whole document *;
		[DA]EP0147850 (THOMAE GMBH DR K [DE]) [DA] 1-9 * the whole document *;
		[DX]EP0207331 (THOMAE GMBH DR K [DE]) [DX] 1-5 * Siehe Verbindungen: RN=108157-52-4, RN=108157-53-5 ;; example - ;
		[A] - GREISCHEL, ANDREAS ET AL, "Quantitation of the new hypoglycemic agent AG-EE 388 ZW in human plasma by automated high-performance liquid chromatography with electrochemical detection", J. CHROMATOGR. (1991), 568(1), 246-52, (1991), XP002117138 [A] 1-5 * the whole document * DOI: http://dx.doi.org/10.1016/0378-4347(91)80360-O
		[A] - "Optical resolution of D,L carnitine nitrile chloride - using N-acetyl- D or L- glutamic acid as resolving agent", DATABASE WPI, 1, Derwent World Patents Index, Database accession no. 1989-195144, XP002117139 & JPH01131143 A 00000000 (EARTH SEIYAKU KK) [A] 6-9 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p